Which serologic assays should be performed to screen for celiac disease in a patient who is still consuming gluten?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Celiac Disease Blood Test Screening

For patients consuming gluten, measure serum IgA anti-tissue transglutaminase (IgA-tTG) antibodies along with total IgA levels as the primary screening approach. 1

Primary Serologic Testing Strategy

The optimal initial testing combination consists of:

  • IgA anti-tissue transglutaminase (IgA-tTG) - the primary screening test
  • Total serum IgA level - to identify IgA deficiency that would cause false-negative results

This two-test approach is superior to other serologic combinations and represents the current standard of care 1.

Critical Pre-Testing Requirement

Patients must be consuming a gluten-containing diet at the time of testing. If gluten has already been restricted, they need to consume 3-6 grams of gluten daily for at least 6 weeks before testing 1. Testing on a gluten-free diet will reduce sensitivity of both serology and biopsy, leading to false-negative results 2.

Algorithm for IgA Deficiency

Selective IgA deficiency (sIgAD) occurs in approximately 2-3% of celiac disease patients - roughly 10-15 times more common than in the general population. When total IgA is low or undetectable:

  • Switch to IgG-based testing: Measure IgG anti-tissue transglutaminase (IgG-tTG) or IgG anti-deamidated gliadin peptides (IgG-DGP) 1, 2
  • Proceed with upper endoscopy and duodenal biopsies 1

Important caveat: IgG-tTG testing is NOT specific in patients with normal IgA levels and should not be used for routine screening 2.

Tests NOT Recommended for Initial Screening

  • IgG anti-deamidated gliadin peptides (DGP-IgG/IgA) - not recommended for initial testing 1
  • IgA anti-endomysial antibodies (EMA-IgA) - while highly specific, this is an immunofluorescence test that is more labor-intensive and should be reserved for confirmatory testing in specific scenarios (such as the no-biopsy pathway when IgA-tTG ≥10× upper limit of normal) 1, 3

Interpretation Framework

The diagnostic accuracy varies by result pattern:

  • Positive IgA-tTG: Likelihood ratio for celiac disease ranges from 20-115 depending on the assay 4
  • IgA-tTG ≥10× upper limit of normal: In symptomatic adults in secondary care, this can support a no-biopsy diagnosis if confirmed with positive EMA-IgA on a second sample 1, 2
  • Negative IgA-tTG with normal total IgA: Likelihood ratio ≤0.12, effectively ruling out celiac disease in most cases 4

Next Steps After Positive Serology

All patients with positive celiac serology should be referred to a gastroenterologist or specialist for confirmation before starting a gluten-free diet 1. The diagnosis typically requires:

  • At least 4 biopsies from the second part of the duodenum (D2)
  • At least 2 biopsies from the duodenal bulb (D1)
  • Histologic confirmation showing increased intraepithelial lymphocytes (>25/100 epithelial cells) plus crypt hyperplasia with or without villous atrophy (Marsh 2-3) 1

Common Pitfalls to Avoid

  1. Testing patients already on a gluten-free diet - this is the most common error leading to false-negative results 2

  2. Using IgG-tTG in patients with normal IgA levels - this lacks specificity and generates false positives 2

  3. Ordering anti-DGP antibodies for initial screening - these are not recommended as first-line tests 1

  4. Starting a gluten-free diet before diagnostic confirmation - this makes subsequent diagnosis extremely difficult and may require a prolonged gluten challenge 1, 2

  5. Failing to measure total IgA - missing IgA deficiency leads to false-negative IgA-tTG results and delayed diagnosis 1, 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.